Epigenetic biomarkers in urological tumors: A systematic review

被引:72
作者
Jeronimo, Carmen [1 ,2 ,4 ]
Henrique, Rui [1 ,3 ,4 ]
机构
[1] Portuguese Oncol Inst, Res Ctr, Canc Epigenet Grp, P-4200072 Oporto, Portugal
[2] Portuguese Oncol Inst, Dept Genet, P-4200072 Oporto, Portugal
[3] Portuguese Oncol Inst, Dept Pathol, P-4200072 Oporto, Portugal
[4] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Pathol & Mol Immunol, P-4099003 Oporto, Portugal
关键词
Epigenetic-based biomarkers; Genitourinary cancer; DNA methylation; Histone modifications; microRNAs; CPG ISLAND HYPERMETHYLATION; PROSTATE-CANCER DETECTION; GLOBAL DNA-METHYLATION; RENAL-CELL CARCINOMA; ABERRANT PROMOTER METHYLATION; HISTONE MODIFICATION PATTERNS; POLYMERASE-CHAIN-REACTION; ANTAGONIST FAMILY GENES; GROUP PROTEIN EZH2; BLADDER-CANCER;
D O I
10.1016/j.canlet.2011.12.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate, bladder, kidney and testis cancers, the most common genitourinary (GU) neoplasms, are generally clinically silent at their earliest stages when curative treatment is most likely successful. However, there are no consensual guidelines for GU cancer screening and available methods are characterized by suboptimal sensitivity and specificity. Moreover, standard clinical and pathological parameters meet with important limitations in the assessment of prognosis in an individual basis. Herein, we focus on the development of epigenetic-based GU cancer biomarkers, which have emerged from exploratory studies in recent years and that hold the promise to revolutionize the clinical management of GU cancer patients. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:264 / 274
页数:11
相关论文
共 157 条
[1]   Evaluation of the Methylation Status of Tumour Suppressor Genes for Predicting Bacillus Calmette-Guerin Response in Patients With T1G3 High-Risk Bladder Tumours [J].
Agundez, Miriam ;
Grau, Laura ;
Palou, Joan ;
Algaba, Ferran ;
Villavicencio, Humberto ;
Sanchez-Carbayo, Marta .
EUROPEAN UROLOGY, 2011, 60 (01) :131-140
[2]   Identification of PMF1 Methylation in Association with Bladder Cancer Progression [J].
Aleman, Ainel ;
Cebrian, Virginia ;
Alvarez, Miguel ;
Lopez, Virginia ;
Orenes, Esteban ;
Lopez-Serra, Lidia ;
Algaba, Ferran ;
Bellmunt, Joaquin ;
Lopez-Beltran, Antonio ;
Gonzalez-Peramato, Pilar ;
Cordon-Cardo, Carlos ;
Garcia, Javier ;
Garcia del Muro, Javier ;
Esteller, Mane ;
Sanchez-Carbayo, Marta .
CLINICAL CANCER RESEARCH, 2008, 14 (24) :8236-8243
[3]   Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer [J].
Ambs, Stefan ;
Prueitt, Robyn L. ;
Yi, Ming ;
Hudson, Robert S. ;
Howe, Tiffany M. ;
Petrocca, Fabio ;
Wallace, Tiffany A. ;
Liu, Chang-Gong ;
Volinia, Stefano ;
Calin, George A. ;
Yfantis, Harris G. ;
Stephens, Robert M. ;
Croce, Carlo M. .
CANCER RESEARCH, 2008, 68 (15) :6162-6170
[4]  
[Anonymous], CA CANC J CLIN, DOI DOI 10.3322/CAAC.20107
[5]   DNA methylation and the regulation of gene transcription [J].
Attwood, JT ;
Yung, RL ;
Richardson, BC .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (02) :241-257
[6]   Predicting Prostate Biopsy Result in Men With Prostate Specific Antigen 2.0 to 10.0 ng/ml Using an Investigational Prostate Cancer Methylation Assay [J].
Baden, Jonathan ;
Adams, Scott ;
Astacio, Tara ;
Jones, Jennifer ;
Markiewicz, Jadwiga ;
Painter, Jennifer ;
Trust, Carrie ;
Wang, Yixin ;
Green, George .
JOURNAL OF UROLOGY, 2011, 186 (05) :2101-2106
[7]   Multicenter Evaluation of an Investigational Prostate Cancer Methylation Assay [J].
Baden, Jonathan ;
Green, George ;
Painter, Jennifer ;
Curtin, Katy ;
Markiewicz, Jadwiga ;
Jones, Jennifer ;
Astacio, Tara ;
Canning, Susan ;
Quijano, Jedidiah ;
Guinto, Wilson ;
Leibovich, Bradley C. ;
Nelson, Joel B. ;
Vargo, Janet ;
Wang, Yixin ;
Wuxiong, Cao .
JOURNAL OF UROLOGY, 2009, 182 (03) :1186-1193
[8]   Genetics and epigenetics of renal cell cancer [J].
Baldewijns, Marcella M. L. ;
van Vlodrop, Iris J. H. ;
Schouten, Leo J. ;
Soetekouw, Patricia M. M. B. ;
de Bruine, Adriaan P. ;
van Engeland, Manon .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2008, 1785 (02) :133-155
[9]   Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer [J].
Banez, Lionel L. ;
Sun, Leon ;
van Leenders, Geert J. ;
Wheeler, Thomas M. ;
Bangma, Chris H. ;
Freedland, Stephen J. ;
Ittmann, Michael M. ;
Lark, Amy L. ;
Madden, John F. ;
Hartman, Arndt ;
Weiss, Gunter ;
Castanos-Velez, Esmeralda .
JOURNAL OF UROLOGY, 2010, 184 (01) :149-156
[10]   IMMUNOHISTOCHEMICAL EVALUATION OF GLOBAL DNA METHYLATION AND H I STONE ACETYLATION IN PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIGNANT POTENTIAL [J].
Barbisan, F. ;
Mazzucchelli, R. ;
Santinelli, A. ;
Stramazzotti, D. ;
Scarpelli, M. ;
Lopez-Beltran, A. ;
Cheng, L. ;
Montironi, R. .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2008, 21 (03) :615-623